Overview

A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to attempt to find better tolerated doses and schedules of this highly effective combination chemotherapy regimen.
Phase:
Phase 2
Details
Lead Sponsor:
Cancer Research Network
Collaborator:
Hoffmann-La Roche
Treatments:
Capecitabine
Docetaxel